Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SLAGELSE RØRSMEDFORRETNING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.4% 2.4%   Bankruptcy risk   6.4% 7.1% 4.8% 4.8% 2.1% 3.9% 11.7% 11.7%   Credit score (0-100)   38 35 45 44 66 49 20 20   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,428 2,131 2,655 2,696 4,520 4,916 0.0 0.0   EBITDA   143 -234 300 206 848 -51.8 0.0 0.0   EBIT   89.9 -286 256 160 779 -194 0.0 0.0   Pre-tax profit (PTP)   51.0 -322.5 227.1 123.6 715.4 -249.6 0.0 0.0   Net earnings   30.0 -261.0 163.5 85.3 544.3 -225.8 0.0 0.0   Pre-tax profit without non-rec. items   51.0 -322 227 124 715 -250 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   134 147 156 228 607 725 0.0 0.0   Shareholders equity total   158 96.9 260 346 890 664 584 584   Interest-bearing liabilities   832 565 601 629 634 546 0.0 0.0   Balance sheet total (assets)   1,682 1,360 2,340 2,621 3,261 2,043 584 584   Net Debt   358 95.0 -650 -1,202 -1,098 -49.9 -584 -584     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,428 2,131 2,655 2,696 4,520 4,916 0.0 0.0   Gross profit growth   20.0% -12.2% 24.6% 1.6% 67.6% 8.8% -100.0% 0.0%   Employees   4 4 4 3 6 7 0 0   Employee growth %   0.0% 0.0% 0.0% -25.0% 100.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,682 1,360 2,340 2,621 3,261 2,043 584 584   Balance sheet change%   15.9% -19.1% 72.0% 12.0% 24.4% -37.3% -71.4% 0.0%   Added value   142.6 -233.6 299.7 205.9 824.6 -51.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -105 -39 -35 27 310 -24 -725 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 3.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.7% -13.4% 9.7% 5.9% 17.2% -4.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.7% -18.8% 13.9% 6.5% 26.5% -7.3% 0.0% 0.0%   ROI %   9.4% -34.6% 33.7% 17.5% 61.8% -13.9% 0.0% 0.0%   ROE %   21.0% -204.8% 91.5% 28.2% 88.1% -29.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   9.4% 7.1% 11.1% 13.2% 27.3% 32.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   250.8% -40.7% -216.9% -583.9% -129.6% 96.4% 0.0% 0.0%   Gearing %   526.6% 582.7% 230.8% 181.9% 71.2% 82.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.8% 5.3% 5.1% 6.0% 10.1% 9.4% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 0.9 1.0 1.0 1.1 0.9 0.0 0.0   Current Ratio   1.0 1.0 1.1 1.1 1.1 1.0 0.0 0.0   Cash and cash equivalent   474.1 469.8 1,251.3 1,831.3 1,732.3 595.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   23.9 -49.9 104.9 118.0 307.3 -27.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   36 -58 75 69 137 -7 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   36 -58 75 69 141 -7 0 0   EBIT / employee   22 -71 64 53 130 -28 0 0   Net earnings / employee   7 -65 41 28 91 -32 0 0